|
Volumn 140, Issue 3, 2005, Pages 295-297
|
Systemic administration of antibodies to glutamate increases seizure threshold for pentylenetetrazole
a a a a a a |
Author keywords
Antibodies; Epileptiform activity; Glutamate; Pentylenetetrazole; Seizures
|
Indexed keywords
ANTIBODY;
ANTICONVULSIVE AGENT;
BOVINE SERUM ALBUMIN;
GLUTAMATE ANTIBODY;
GLUTAMATE RECEPTOR ANTAGONIST;
IMMUNOGLOBULIN;
PENTETRAZOLE;
SODIUM CHLORIDE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTICONVULSANT ACTIVITY;
ARTICLE;
CLONIC SEIZURE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG MECHANISM;
GENERALIZED EPILEPSY;
LETHALITY;
MALE;
MOUSE;
MOUSE STRAIN;
NONHUMAN;
PASSIVE IMMUNIZATION;
SEIZURE THRESHOLD;
TONIC SEIZURE;
TREATMENT OUTCOME;
ANIMALS;
ANTIBODIES;
ANTICONVULSANTS;
GLUTAMIC ACID;
MALE;
MICE;
MICE, INBRED C57BL;
PENTYLENETETRAZOLE;
SEIZURES;
SERUM ALBUMIN, BOVINE;
ANIMALIA;
BOVINAE;
|
EID: 28844492187
PISSN: 00074888
EISSN: None
Source Type: Journal
DOI: 10.1007/s10517-005-0471-3 Document Type: Article |
Times cited : (5)
|
References (10)
|